Armando Anido Zynerba Pharmaceuticals, Inc. (ZYNE) insider trading activity

Armando Anido is Chairman & Chief Exec. Officer of Zynerba Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of ZYNE, which is worth approximately $0. The most recent transaction as insider was on Oct 10, 2023, when has been sold 1,176,722 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

ARMANDO ANIDO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 10 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	1,176,722 Reduced 100.0%	0 Common Stock
Oct 10 2023	BUY Grant, award, or other acquisition	-	240,000 Added 28.24%	610,000 Common Stock
Sep 13 2023	SELL Open market or private sale	$23,713 $1.33 p/Share	17,830 Reduced 1.87%	936,722 Common Stock
Sep 12 2023	BUY Grant, award, or other acquisition	-	64,747 Added 6.35%	954,552 Common Stock
Feb 08 2023	SELL Payment of exercise price or tax liability	$7,528 $0.6 p/Share	12,547 Reduced 1.39%	889,805 Common Stock
Feb 07 2023	BUY Grant, award, or other acquisition	-	45,406 Added 4.79%	902,352 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$7,035 $0.6 p/Share	11,726 Reduced 1.35%	856,946 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	42,437 Added 4.66%	868,672 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	250,000 Added 23.23%	826,235 Common Stock
Jan 23 2023	SELL Open market or private sale	$21,271 $0.6 p/Share	35,453 Reduced 5.8%	576,235 Common Stock
Jul 19 2022	SELL Open market or private sale	$13,089 $1.1 p/Share	11,899 Reduced 1.91%	611,688 Common Stock
Jul 18 2022	BUY Grant, award, or other acquisition	-	43,164 Added 6.47%	623,587 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	120,000 Added 17.13%	580,423 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	107,911 Added 18.99%	460,423 Common Stock

Also insider at

SCYX

SCYNEXIS INC Healthcare

Armando Anido

Chairman & Chief Exec. Officer

Devon, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYNE shares.

Notify only if

Value

Insider Trading

Get notified when an Zynerba Pharmaceuticals, Inc. insider buys or sells ZYNE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Zynerba Pharmaceuticals, Inc.

Track Activities on ZYNE

Account